OECD | Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk: Case study on tissue injury


Your substances

None


The Organisation for Economic Cooperation and Development (OECD) Working Party on Manufactured Nanomaterials (WPMN) project, “Advancing Adverse Outcome Pathway Development for Nanomaterial Risk Assessment and Categorisation (NanoAOP project)” contributes to both the future development and the potential application of AOPs for manufactured nanomaterial (MN) regulatory decision making. This document was developed as part of the OECD project Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk Assessment and Categorisation. It outlines the methodology, through a case study approach, for identifying key events (KEs) that could support development of AOPs relevant for MNs.

Link to the OECD | Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk: Case study on tissue injury

                   

Related News

Loading...